Literature DB >> 25103575

Early treatment is associated with improved cognition in Hurler syndrome.

Michele D Poe1, Sarah L Chagnon, Maria L Escolar.   

Abstract

OBJECTIVE: Hurler syndrome is the most clinically severe form of an autosomal recessive lysosomal disorder characterized by the deficiency of α-L-iduronidase. The resulting accumulation of glycosaminoglycans causes progressive multisystem deterioration, resulting in death in childhood. Umbilical cord blood transplantation from unrelated donors has been previously shown to improve neurological outcomes of children <2 years of age and prolong life. The purpose of this article is to determine whether age at transplantation can predict cognitive outcomes.
METHODS: Between June 1997 and February 2013, 31 patients with Hurler syndrome underwent umbilical cord blood transplantation and were evaluated at baseline and every 6 to 12 months thereafter. All 31 patients underwent complete neurodevelopmental evaluation (median follow-up = 7.3 years, range = 2-21.7) and a median of 7.0 evaluations (range = 3-18).
RESULTS: Younger age at transplantation was associated with improved cognitive function (p = 0.001), receptive and expressive language (p = 0.004 and p = 0.01), and adaptive behavior (p = 0.03).
INTERPRETATION: Early age at transplantation is a strong predictor of cognitive, language, and adaptive behavior outcomes. Children younger than 9 months at the time of transplant showed normal cognitive development. Our results demonstrate that early diagnosis is necessary for optimal outcomes and support the need for newborn screening, because most patients are not identified at this young age.
© 2014 American Neurological Association.

Entities:  

Mesh:

Year:  2014        PMID: 25103575     DOI: 10.1002/ana.24246

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  32 in total

Review 1.  Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.

Authors:  Madeleine Taylor; Shaukat Khan; Molly Stapleton; Jianmin Wang; Jing Chen; Robert Wynn; Hiromasa Yabe; Yasutsugu Chinen; Jaap Jan Boelens; Robert W Mason; Francyne Kubaski; Dafne D G Horovitz; Anneliese L Barth; Marta Serafini; Maria Ester Bernardo; Hironori Kobayashi; Kenji E Orii; Yasuyuki Suzuki; Tadao Orii; Shunji Tomatsu
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-14       Impact factor: 5.742

2.  Effectiveness of Early Hematopoietic Stem Cell Transplantation in Preventing Neurocognitive Decline in Mucopolysaccharidosis Type II: A Case Series.

Authors:  A Selvanathan; C Ellaway; C Wilson; P Owens; P J Shaw; K Bhattacharya
Journal:  JIMD Rep       Date:  2018-04-19

3.  Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment.

Authors:  Elsa G Shapiro; Igor Nestrasil; Kyle Rudser; Kathleen Delaney; Victor Kovac; Alia Ahmed; Brianna Yund; Paul J Orchard; Julie Eisengart; Gregory R Niklason; Julian Raiman; Eva Mamak; Morton J Cowan; Mara Bailey-Olson; Paul Harmatz; Suma P Shankar; Stephanie Cagle; Nadia Ali; Robert D Steiner; Jeffrey Wozniak; Kelvin O Lim; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2015-06-17       Impact factor: 4.797

4.  Long-term functional outcomes of children with hurler syndrome treated with unrelated umbilical cord blood transplantation.

Authors:  Hannah Y Coletti; Mieke Aldenhoven; Karina Yelin; Michele D Poe; Joanne Kurtzberg; Maria L Escolar
Journal:  JIMD Rep       Date:  2015-01-23

5.  Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.

Authors:  Francyne Kubaski; Robert W Mason; Akiko Nakatomi; Haruo Shintaku; Li Xie; Naomi N van Vlies; Heather Church; Roberto Giugliani; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Tadao Orii; Toshiyuki Fukao; Adriana M Montaño; Shunji Tomatsu
Journal:  J Inherit Metab Dis       Date:  2016-10-07       Impact factor: 4.982

Review 6.  Cognitive outcomes and age of detection of severe mucopolysaccharidosis type 1.

Authors:  Scott D Grosse; Wendy K K Lam; Lisa D Wiggins; Alex R Kemper
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

7.  Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.

Authors:  Sevil Köse; Fatima Aerts-Kaya; Duygu Uçkan Çetinkaya; Petek Korkusuz
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.

Authors:  Ryan D Geraets; Seung yon Koh; Michelle L Hastings; Tammy Kielian; David A Pearce; Jill M Weimer
Journal:  Orphanet J Rare Dis       Date:  2016-04-16       Impact factor: 4.123

9.  The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences.

Authors:  Stefano Bruni; Christine Lavery; Alexander Broomfield
Journal:  Mol Genet Metab Rep       Date:  2016-08-02

10.  Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant.

Authors:  Leonor Arranz; Luis Aldamiz-Echevarria
Journal:  Mol Genet Metab Rep       Date:  2015-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.